Loading company…
PhaseV provides machine learning tools for adaptive clinical trial design and execution.
Founded in 2023 and based in Tel Aviv, Israel, PhaseV develops machine learning technology and statistical methods for adaptive clinical trial design and execution. Its platform provides trial insights and recommendations, supports resource allocation, and helps teams use trial data. The company was co-founded by Raviv Pryluk, Elad Berkman, and Dan Goldstaub. In May 2025, it raised USD 50 million in Series A funding co-led by Accel and Insight Partners, with Viola Ventures, EXOR, and LionBird participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in